NewAmsterdam Pharma has said that an oral drug it is developing to lower cholesterol has shown preliminary efficacy as a ...

A Chinese company that developed the country’s first indigenous therapy for Alzheimer’s disease has suspended production and sales of the drug, casting doubts on the treatment’s future.

See here for Eisai (ESALF) stock analysis including Leqembi's EU approval, growth potential, and industry valuation amid ...

Content by Methodist Health System. June is Alzheimer’s and Brain Awareness Month, which means there’s no better time to ...

New dementia diagnoses have significantly decreased since 2015, a study published in BMJ found.But more people are living ...

The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person’s blood to diagnose ...

June is Alzheimer’s & Brain Awareness Month, and the Alzheimer’s Association is reinforcing how important everybody’s ...

More people in the U.S. South are prescribed a sought-after Alzheimer's-slowing drug compared to those in the Northeast, a ...

A study of mice and people looks at how the brain takes an experience, like being cut off in traffic, and responds with an ...

Over the past decade, Ralph got involved with the Maine Running Club and began signing up for more road races. When he ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day.

Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly ...